Alumis

United States
Wrightstown, Wisconsin, United States, 94108

Company profile

Alumis company profile

Alumis develops precision medications to treat autoimmune illnesses. The company's analytics platform and understanding of immunologic disorders aid in the development of treatments and medications for autoimmune diseases, allowing patients to alleviate suffering and modify their way of life.

Business identity

Contact email
[email protected]
Phone number
+1- 650-231-6625
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Postal code
94108
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
6
Total equity funding
$914.1M
Last funding
Post IPO Equity / $345.1M / 2026-01-07
Last equity funding
Post IPO Equity / $345.1M
Investors
12
Lead investors
4
Founders
1
Articles
162
Exited on
2024-06-28

Founders and investors

Founders

June Lee

Lead investors

Foresite CapitalMatrix Capital ManagementSamsara BioCapitalvenBio Partners

Investors

Cormorant Asset ManagementForesite CapitalOmega FundsSamsara BioCapitalSR One